Abstract:BackgroundPrevalence of cobalamin deficiency is high especially in older patients and an immediate therapy start is necessary to prevent irreversible neurological damages. Unfortunately, the diagnosis of cobalamin deficiency is difficult and at present, there is no consensus for diagnosis of this deficiency. Therefore, we aim to elucidate a meaningful diagnostic pathway by a case report with an initially misleading medical history.Case presentationA 57 year-old Caucasian man suffering from dramatic myelosis of… Show more
“…Instead, the levels of methylmalonic acid, homocysteine [9], and holotranscobalamin (known as “active B 12 ”) [12] are better biomarkers for diagnosis of vitamin B 12 deficiency. Therefore, a normal serum vitamin B 12 level cannot be used to exclude genuine vitamin B 12 deficiency [13] and damage in this condition. The term “functional vitamin B 12 deficiency” [9] is thus used to take the above considerations into account.…”
Section: Discussionmentioning
confidence: 99%
“…Different treatments for vitamin B 12 deficiency have been described in the literature [1, 13-16]. To our knowledge, there are as yet no guidelines regarding a therapeutic regimen for patients with SCD.…”
Purpose: The study aimed to analyze the clinical characteristics, laboratory test results, neuroimaging findings, and outcomes in patients diagnosed with subacute combined degeneration (SCD). Materials and Methods: A total of 68 patients with SCD who had been appropriately treated for no less than 6 months were included in our study. Histories, results of routine blood tests, biochemical indices, serum vitamin B12 levels, and spinal magnetic resonance imaging (MRI) findings from the patients were studied and analyzed. Clinical signs and symptoms, graded using a functional disability rating scale, were scored at the time of admission and 3 and 6 months after admission. Results: Limb numbness, limb weakness, and gait disturbances were the most common symptoms in patients with SCD. All patients showed clinical improvement to different degrees at the follow-up visits after vitamin B12 treatment. No differences in rating score were found in patients grouped by sex, hemoglobin level, serum vitamin B12, or MRI manifestations at the time of admission or at the follow-up visits. Younger patients and those with shorter disease courses had better rating scores at the short-term follow-up visits. Conclusion: Anemia, low levels of serum vitamin B12, and MRI abnormalities in the spinal cord are not expected to be associated with worse clinical manifestations. The age of onset and course of disease are important in evaluating the short-term prognosis of patients with SCD.
“…Instead, the levels of methylmalonic acid, homocysteine [9], and holotranscobalamin (known as “active B 12 ”) [12] are better biomarkers for diagnosis of vitamin B 12 deficiency. Therefore, a normal serum vitamin B 12 level cannot be used to exclude genuine vitamin B 12 deficiency [13] and damage in this condition. The term “functional vitamin B 12 deficiency” [9] is thus used to take the above considerations into account.…”
Section: Discussionmentioning
confidence: 99%
“…Different treatments for vitamin B 12 deficiency have been described in the literature [1, 13-16]. To our knowledge, there are as yet no guidelines regarding a therapeutic regimen for patients with SCD.…”
Purpose: The study aimed to analyze the clinical characteristics, laboratory test results, neuroimaging findings, and outcomes in patients diagnosed with subacute combined degeneration (SCD). Materials and Methods: A total of 68 patients with SCD who had been appropriately treated for no less than 6 months were included in our study. Histories, results of routine blood tests, biochemical indices, serum vitamin B12 levels, and spinal magnetic resonance imaging (MRI) findings from the patients were studied and analyzed. Clinical signs and symptoms, graded using a functional disability rating scale, were scored at the time of admission and 3 and 6 months after admission. Results: Limb numbness, limb weakness, and gait disturbances were the most common symptoms in patients with SCD. All patients showed clinical improvement to different degrees at the follow-up visits after vitamin B12 treatment. No differences in rating score were found in patients grouped by sex, hemoglobin level, serum vitamin B12, or MRI manifestations at the time of admission or at the follow-up visits. Younger patients and those with shorter disease courses had better rating scores at the short-term follow-up visits. Conclusion: Anemia, low levels of serum vitamin B12, and MRI abnormalities in the spinal cord are not expected to be associated with worse clinical manifestations. The age of onset and course of disease are important in evaluating the short-term prognosis of patients with SCD.
“…Index case presented in a sick condition with severe anemia, low platelet and hemolysis, prompting clinician to suspect HELLP syndrome. However low leukocyte count is unusual in HEELP unless disseminated intravascular coagulopathy (DIC) ensue (5).…”
Introduction: Hemolysis, Elevated liver enzyme, low platelet (HELLP) syndrome is often noted as a complication of preeclampsia but can occur without this association as well. Severe form often requires termination of pregnancy. Vitamin B12 deficiency is common in vegetarian population and can mimic HELLP syndrome.
Case Summary: We present an interesting case which was initially thought to be HELLP syndrome based on the clinical presentation and patient was planned for induction of labour, but later on it was found out to be a case of Vitamin B12 deficiency on the basis of Lab findings. Patient responded well to the B12 supplementation and unjustified termination of pregnancy was avoided.
Conclusion: This case illustrates an interesting clinical misdiagnosis of HELLP syndrome in an overt megaloblastic anemia. An elaborated workup with clinical suspicion should be made for megaloblastic anemia in such condition.
Keywords: HELLP syndrome, Megaloblastic Anemia, Vitamin B12 deficiency, Pregnancy
“…The finding of a band of thoracic sensory impairment would not be expected with SCD and would be more compatible with TM. A review of the literature identified that both sensory levels and bands of abnormal sensation on the chest have been reported in SCD [3–5]. Although a sensory level might be explained by rare spinothalamic tract involvement [5], there is no satisfactory explanation for the band of abnormal sensation.…”
Section: Discussionmentioning
confidence: 99%
“…Clearly defined sensory level [1] May have thoracic sensory level due to spinothalamic tract involvement [3,5] or band of abnormal sensation on thorax [4,5] Painful, circumferential band of reduced pinprick and temperature at T5eT6 enlargement and no gadolinium enhancement, considered likely TM ( Figure 1A). Brain, thoracic, and lumbosacral spine images showed no abnormalities.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.